Literature DB >> 22989030

An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.

Nancy S Elbarbary1, Erling Tjora, Janne Molnes, Benedicte A Lie, Mohammad A Habib, Mona A Salem, Pål Rasmus Njølstad.   

Abstract

The SLC29A3 gene, encoding hENT3, a member of the equilibrative nucleoside transporter family, has recently been found mutated in Faisalabad histiocytosis, pigmented hypertrichotic dermatosis with insulin-dependent diabetes, familial sinus histiocytosis with massive lymphadenopathy (SHML), and H syndromes. We here report clinical and genetic findings of an Egyptian family with H syndrome. We describe two siblings, a 19-yr old girl and a 15-yr old boy, of consanguineous parents. From 5 yr of age, the girl developed bilateral flexion deformity of interphalengeal joints and insulin-dependent diabetes mellitus. At age 7 yr, prominent hyperpigmented patches appeared on the skin at lower limbs, genitalia, and trunk. On clinical examination, she had hepatosplenomegaly, generalized lymphadenopathy, left ventricular hypertrophy, sensorineural hearing loss, hypogonadism, short stature, and characteristic dysmorphic features. Her brother had fixed flexion contractures of the feet, profound sensorineural hearing loss, characteristic dysmorphic features, but no diabetes. DNA sequence analysis revealed a homozygous mutation (c.300+1G>C) in SLC29A3 in both siblings. The phenotype and genotype of the siblings were compatible with that of the H syndrome, although the features were overlapping with those found in pigmented hypertrichotic dermatosis with insulin-dependent diabetes, familial SHML, and Faisalabad histiocytosis, indicating that these four syndromes may be regarded as one disease with varying phenotypic features. A new, common name for these conditions is warranted.
© 2012 John Wiley & Sons A/S.

Entities:  

Keywords:  diabetes; gene; mutation; syndrome

Mesh:

Substances:

Year:  2012        PMID: 22989030     DOI: 10.1111/j.1399-5448.2012.00925.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  9 in total

1.  Mutation in the SLC29A3 Gene in an Egyptian Patient with H Syndrome: A Case Report and Review of Literature.

Authors:  Hala T El-Bassyouni; Manal M Thomas; Angie M S Tosson
Journal:  J Pediatr Genet       Date:  2019-09-30

Review 2.  First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis.

Authors:  Alissa Trzeciak; Ya-Ting Wang; Justin Shaun Arnold Perry
Journal:  Cell Metab       Date:  2021-08-24       Impact factor: 31.373

3.  Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.

Authors:  Madhu Pujar; Basavaraj Vastrad; Satish Kavatagimath; Chanabasayya Vastrad; Shivakumar Kotturshetti
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

4.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

5.  The histopathology and phenotypic variability in H syndrome.

Authors:  David Dias-Polak; Margarita Indelman; Reuven Bergman; Emily Avitan-Hersh
Journal:  Clin Case Rep       Date:  2018-01-25

6.  Adult stem cell deficits drive Slc29a3 disorders in mice.

Authors:  Sreenath Nair; Anne M Strohecker; Avinash K Persaud; Bhawana Bissa; Shanmugam Muruganandan; Craig McElroy; Rakesh Pathak; Michelle Williams; Radhika Raj; Amal Kaddoumi; Alex Sparreboom; Aaron M Beedle; Rajgopal Govindarajan
Journal:  Nat Commun       Date:  2019-07-03       Impact factor: 14.919

7.  Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.

Authors:  Hamza Chouk; Mohamed Ben Rejeb; Lobna Boussofara; Haїfa Elmabrouk; Najet Ghariani; Badreddine Sriha; Ali Saad; Dorra H'Mida; Mohamed Denguezli
Journal:  Hum Genomics       Date:  2021-10-17       Impact factor: 4.639

Review 8.  Review of the current literature on H syndrome treatment.

Authors:  Kimia Saleh Anaraki; Sepehr Khosravi; Elham Behrangi; Afsaneh Sadeghzadeh-Bazargan; Azadeh Goodarzi
Journal:  J Family Med Prim Care       Date:  2022-03-10

9.  The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis.

Authors:  Mahmoud Mikdar; Pedro González-Menéndez; Xiaoli Cai; Yujin Zhang; Marion Serra; Abdoul K Dembele; Anne-Claire Boschat; Sylvia Sanquer; Cerina Chhuon; Ida Chiara Guerrera; Marc Sitbon; Olivier Hermine; Yves Colin; Caroline Le Van Kim; Sandrina Kinet; Narla Mohandas; Yang Xia; Thierry Peyrard; Naomi Taylor; Slim Azouzi
Journal:  Blood       Date:  2021-06-24       Impact factor: 25.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.